UK Healthcare 2000 Forum
Healthcare 2000 is a new forum which has been set up to review the future of health care in the UK. It is financed by the international drug industry group Pharmaceutical Partners for Better Healthcare, but says it is independent of any sectional interests. Its 12-member steering committee is chaired by Sir Duncan Nichol, former Health Services management Executive chief executive.
Spokesmen for Healthcare 2000 say its aims are to: - review current research on the future of the National Health Service; - stimulate debate among interested parties; - disseminate the discussion to a wide audience; and - produce an authoritative report on future options for health care in the UK.
They add that it will make a "vital contribution" to discussions on the future of health care, improving the quality of the public debate "so that voters better understand the necessity for change in health care, and so ease the potentially highly-charged political process that will be needed to bring that about."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze